To prove the special role of CD44+ cells in initiation and maintenance of tumor when administered EC even in minimal doses, it was of interest to comparatively assess the tumorigenic capacity of isolated CD44+ and CD44– fractions when administered at various concentrations. This evidence concerns the gene CD44 and neoplasm.